JPRN-jRCT2080222906未知3 期
ong-term study of HP-3150 in patients with cancer pain.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients confirmed to have various types of cancer who were informed about their disease.
排除标准
- •-Patients with abnormalities at the planned application site.
- •-Patients with a serious hematologic disorder, hepatic dysfunction, renal dysfunction, hypertension, or heart failure.
研究者
相似试验
已完成
3 期
Phase III study of HP-3150Cancer painJPRN-jRCT2080223595Hisamitsu Pharmaceutical Co., Inc.341
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
3 期
ong-term study of TA-8317 in patients with cancer breakthrough paiCancer breakthrough painJPRN-jRCT2080220302Mitsubishi Tanabe Pharma Corporation
未知
3 期
ong-term study of HP-3000 in patients with Parkinson's diseaseParkinson's diseaseJPRN-jRCT2080222696Hisamitsu Pharmaceutical Co.,Inc.